Literature DB >> 20162625

Discovery and characterization of a mammalian amyloid disaggregation activity.

Amber N Murray1, James P Solomon, Ya-Juan Wang, William E Balch, Jeffery W Kelly.   

Abstract

The formation of amyloid, a cross-beta-sheet fibrillar aggregate, is associated with a variety of aging-associated degenerative diseases. Herein, we report the existence of a mammalian amyloid disaggregase activity that is present in all tissues and cell types tested. Homogenates from mammalian tissues and cell lines are able to disaggregate amyloid fibrils composed of amyloid beta (A beta)(1-40) or the 8 kDa plasma gelsolin fragment. The mammalian disaggregase activity is sensitive to proteinase K digestion and can be uncoupled from proteolysis activity using a protease inhibitor cocktail. Amyloid disaggregation and proteolysis activities are remarkably resistant to changes in temperature and pH. Identification and manipulation of the proteins responsible for the amyloid disaggregation/degradation activities offers the possibility of ameliorating aggregation-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20162625      PMCID: PMC2867023          DOI: 10.1002/pro.363

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  45 in total

Review 1.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

2.  A general strategy for the bacterial expression of amyloidogenic peptides using BCL-XL-1/2 fusions.

Authors:  Isaac T Yonemoto; Malcolm R Wood; William E Balch; Jeffery W Kelly
Journal:  Protein Sci       Date:  2009-09       Impact factor: 6.725

3.  Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity.

Authors:  Kenji Usui; John D Hulleman; Johan F Paulsson; Sarah J Siegel; Evan T Powers; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

Review 4.  Biological and chemical approaches to diseases of proteostasis deficiency.

Authors:  Evan T Powers; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly; William E Balch
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 5.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

6.  A kinetic assessment of the C. elegans amyloid disaggregation activity enables uncoupling of disassembly and proteolysis.

Authors:  Jan Bieschke; Ehud Cohen; Amber Murray; Andrew Dillin; Jeffery W Kelly
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

Review 7.  Polyglutamine diseases: emerging concepts in pathogenesis and therapy.

Authors:  Jieya Shao; Marc I Diamond
Journal:  Hum Mol Genet       Date:  2007-10-15       Impact factor: 6.150

8.  Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins.

Authors:  Lesley J Page; Ji Young Suk; Lyudmila Bazhenova; Sheila M Fleming; Malcolm Wood; Yun Jiang; Ling T Guo; Andrew P Mizisin; Robert Kisilevsky; G Diane Shelton; William E Balch; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-19       Impact factor: 11.205

9.  Stress, aging, and neurodegenerative disease.

Authors:  Richard I Morimoto
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 176.079

Review 10.  Adapting proteostasis for disease intervention.

Authors:  William E Balch; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly
Journal:  Science       Date:  2008-02-15       Impact factor: 63.714

View more
  18 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  Protein folding: The dark side of proteins.

Authors:  Jim Schnabel
Journal:  Nature       Date:  2010-04-08       Impact factor: 49.962

Review 3.  Spatial protein quality control and the evolution of lineage-specific ageing.

Authors:  Thomas Nyström
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-12       Impact factor: 6.237

4.  Surface adsorption considerations when working with amyloid fibrils in multiwell plates and Eppendorf tubes.

Authors:  Amber N Murray; Fernando L Palhano; Jan Bieschke; Jeffery W Kelly
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

Review 5.  Protein rescue from aggregates by powerful molecular chaperone machines.

Authors:  Shannon M Doyle; Olivier Genest; Sue Wickner
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10       Impact factor: 94.444

Review 6.  Cellular strategies of protein quality control.

Authors:  Bryan Chen; Marco Retzlaff; Thomas Roos; Judith Frydman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

7.  Metazoan Hsp70 machines use Hsp110 to power protein disaggregation.

Authors:  Heike Rampelt; Janine Kirstein-Miles; Nadinath B Nillegoda; Kang Chi; Sebastian R Scholz; Richard I Morimoto; Bernd Bukau
Journal:  EMBO J       Date:  2012-09-18       Impact factor: 11.598

8.  Mechanism of an ATP-independent protein disaggregase: II. distinct molecular interactions drive multiple steps during aggregate disassembly.

Authors:  Peera Jaru-Ampornpan; Fu-Cheng Liang; Alex Nisthal; Thang X Nguyen; Pengcheng Wang; Kuang Shen; Steven L Mayo; Shu-Ou Shan
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

9.  Extraneural manifestations of prion infection in GPI-anchorless transgenic mice.

Authors:  Andrew M Lee; Johan F Paulsson; Justin Cruite; Abegail A Andaya; Matthew J Trifilo; Michael B A Oldstone
Journal:  Virology       Date:  2011-01-11       Impact factor: 3.616

10.  Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils.

Authors:  Fernando L Palhano; Jiyong Lee; Neil P Grimster; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2013-05-07       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.